Rankings
▼
Calendar
PGNY
Progyny, Inc.
$1B
Q4 2025 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$318M
+6.7% YoY
Gross Profit
$77M
24.1% margin
Operating Income
$15M
4.8% margin
Net Income
$12M
3.9% margin
EPS (Diluted)
$0.14
QoQ Revenue Growth
+1.6%
Cash Flow
Operating Cash Flow
$54M
Free Cash Flow
$49M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$742M
Total Liabilities
$226M
Stockholders' Equity
$516M
Cash & Equivalents
$112M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$318M
$298M
+6.7%
Gross Profit
$77M
$63M
+21.2%
Operating Income
$15M
$16M
-3.6%
Net Income
$12M
$11M
+18.5%
Revenue Segments
Fertility benefit services revenue
$209M
66%
Pharmacy benefit services revenue
$110M
34%
← FY 2025
All Quarters
PGNY Q4 2025 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena